(A) The recurrence-free probability of patients with high mitotic count (n=175) was the lowest (5-year recurrence-free probability=73%), followed by intermediate (n=106, 80%), and low (n=204, 91%). (B) The recurrence-free probability of patients with high architectural grade (n=78) was the lowest (68%), followed by intermediate (n=371, 84%), and low (n=36, 92%). (C) Within the intermediate architectural grade, patients with low mitotic count (n=165) had higher 5-year recurrence-free probability (92%) compared to the intermediate (n=91, 77%) – high mitotic count (n=115, 79%). (D) Within the high architectural grade, patients with high mitotic count (n=58) had lower 5-year recurrence-free probability (60%) compared to the low (n=7, 86%) – intermediate mitotic count (n=13, 100%).